Study guide

6.2 Target Heart Rate Calculation, Hemodynamic Monitoring & Test Termination Criteria

CCI Certified Cardiographic Technician Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiac Anatomy, Electrophysiology & Pre-Procedural Patient Care

1.1 Cardiac Anatomy & Blood Flow Pathway 1.2 Cardiac Electrophysiology & Conduction System 1.3 Pre-Procedural Patient Care, Identification & Infection Control 1.4 Cardiovascular Pharmacology & Cardiac Medications

2 Chapter 2: 12-Lead ECG Technique, Lead Placement & Technical Quality

2.1 Bipolar & Augmented Limb Leads (Einthoven's Triangle) 2.2 Precordial Lead Placement (V1-V6) & Special Lead Configurations (V7-V9, Right-Sided, Dextrocardia, Pediatric, 15-Lead) 2.3 ECG Paper Calibration, Grid Standards & Speed Settings 2.4 ECG Artifact Recognition, Signal Interference & Technical Troubleshooting

3 Chapter 3: Analyzing the 12-Lead ECG (Axis, Hypertrophy & Ischemia)

3.1 Cardiac Axis Determination & Axis Deviations 3.2 Chamber Hypertrophy (Atrial & Ventricular) 3.3 Ischemic Changes, Injury & Infarction Patterns

4 Chapter 4: ECG Waveform Analysis & Rhythm Recognition

4.1 Normal Sinus Rhythm & Sinus Node Dysrhythmias 4.2 Atrial Dysrhythmias (PACs, Atrial Fibrillation, Atrial Flutter, SVT) 4.3 Junctional Rhythmias & AV Nodal Reentry 4.4 Ventricular Dysrhythmias (PVCs, Ventricular Tachycardia, Ventricular Fibrillation, Torsades de Pointes) 4.5 Atrioventricular (AV) Blocks (1st Degree, 2nd Degree Type I/II, 3rd Degree Complete) 4.6 Intraventricular Conduction Delay, Bundle Branch Blocks & WPW Pattern 4.7 Pacemaker Rhythmias, Spike Analysis & Pacemaker Malfunctions

5 Chapter 5: Ambulatory ECG Monitoring (Holter, Event & Telemetry)

5.1 Holter Monitoring (24-48 Hour Continuous Recording) & Lead Placement 5.2 Cardiac Event Monitors, Mobile Cardiac Telemetry (MCT), Patch Recorders & Implantable Loop Recorders 5.3 Patient Diary Correlation, Symptom Tracking & Data Analysis

6 Chapter 6: Exercise & Pharmacologic Cardiac Stress Testing

6.1 Treadmill Stress Test Protocols 6.2 Target Heart Rate Calculation, Hemodynamic Monitoring & Test Termination Criteria 6.3 Pharmacologic Stress Testing Agents 6.4 Complications & Emergency Protocols During Stress Testing

7 Chapter 7: Equipment Quality Control, Calibration & Compliance Standards

7.1 Equipment Calibration, Voltage Standards & Frequency Filters 7.2 Electrical Safety, Patient Grounding & Equipment Maintenance 7.3 Quality Assurance, Documentation & HIPAA/Regulatory Compliance

6.2 Target Heart Rate Calculation, Hemodynamic Monitoring & Test Termination Criteria

Key Takeaways Explain This Topic AI

Target Heart Rate (THR) for diagnostic stress testing is calculated as 85% of Age-Predicted Maximal Heart Rate (220 - age).

Absolute termination criteria include a drop in systolic BP > 10 mmHg with ischemia, or sustained VT.

Normal BP response during exercise is a progressive increase in systolic BP with minimal change or slight decrease in diastolic BP.

A blunted or hypotensive blood pressure response can indicate severe left ventricular dysfunction or severe ischemia.

Last updated: July 2026

Target Heart Rate Calculation, Hemodynamic Monitoring & Test Termination

Quick Answer: A diagnostic stress test must reach 85% of the patient's age-predicted maximal heart rate. Close monitoring of BP, HR, and symptoms is essential, with strict absolute and relative criteria for ending the test.

During any cardiac stress test, continuous monitoring of the patient's hemodynamics (blood pressure and heart rate) and electrocardiogram (ECG) is mandatory. The primary goal is to achieve a diagnostic level of cardiovascular stress safely, allowing clinicians to observe how the heart performs under increased metabolic demand. Meticulous observation is required because the physiological stress induced by the test can unmask severe underlying pathologies, occasionally precipitating life-threatening events. The technician must be vigilant, constantly assessing the patient's clinical appearance, communicating with them about their symptoms, and correlating these subjective reports with the objective data displayed on the monitors. A stress test is a dynamic procedure, and the decision to continue or terminate relies heavily on real-time interpretation of these evolving hemodynamic and electrical parameters.

Target Heart Rate (THR) Calculation

For a stress test to be considered diagnostically adequate (especially for evaluating ischemia), the patient must reach their Target Heart Rate (THR) . This threshold is critical because it ensures that the heart has been sufficiently stressed to reveal any potential flow-limiting blockages in the coronary arteries. If the heart is not pushed hard enough, a significant stenosis might not manifest as ischemia, leading to a false-negative result.

The standard formula is: Age-Predicted Maximal Heart Rate (APMHR) = 220 - Age Target Heart Rate = 85% × (220 - Age)

Example: For a 60-year-old patient:

  • APMHR = 220 - 60 = 160 bpm
  • THR = 160 × 0.85 = 136 bpm

If a patient fails to reach 85% of their APMHR and the test is stopped (due to fatigue, for example), the test may be classified as "nondiagnostic" for ischemia. In such cases, pharmacological stress testing might be recommended as an alternative. It is also important to note that achieving 100% of the APMHR provides even more diagnostic certainty, but 85% is the generally accepted minimum threshold for a valid study.

Target HR Calculations by Age Table

  • Patient Age (Years) Max HR (220 - age) 85% Target HR (Diagnostic Minimum) 100% Max HR (Optimal Goal)
  • 30 190 bpm 162 bpm 190 bpm
  • 40 180 bpm 153 bpm 180 bpm
  • 50 170 bpm 145 bpm 170 bpm
  • 60 160 bpm 136 bpm 160 bpm
  • 70 150 bpm 128 bpm 150 bpm
  • 80 140 bpm 119 bpm 140 bpm
  • Expected Hemodynamic Responses

Understanding the normal physiological response to exercise is essential for recognizing pathological deviations during a stress test.

Heart Rate: Should increase linearly with workload and oxygen demand. Failure to increase appropriately is termed "chronotropic incompetence" and may indicate sinus node dysfunction, autonomic neuropathy, or the suppressive effect of medications like beta-blockers or calcium channel blockers.

Systolic Blood Pressure (SBP): Should increase progressively with workload (typically 10-20 mmHg per MET). This increase reflects the enhanced cardiac output necessary to perfuse working muscles.

Diastolic Blood Pressure (DBP): Should remain relatively unchanged or decrease slightly. This occurs due to profound systemic vasodilation in the exercising skeletal muscles, which decreases overall peripheral vascular resistance.

Abnormal BP Response: A drop in SBP of > 10 mmHg from baseline, or a failure of SBP to rise with increased workload, is a significant warning sign. It often indicates severe left ventricular dysfunction or extensive, multi-vessel coronary artery disease causing global ischemia and pump failure.

Test Termination Criteria

The ACC/AHA guidelines provide specific criteria for when to terminate a stress test immediately. These are divided into absolute (must stop immediately) and relative (stop based on clinical judgment) criteria. Adherence to these guidelines is non-negotiable for patient safety.

Absolute vs Relative Stress Test Termination Criteria Table

Category Termination Criteria Description Clinical Rationale

Absolute Drop in systolic BP > 10 mmHg from baseline with evidence of ischemia (e.g., angina). Indicates severe left ventricular dysfunction or global ischemia (pump failure).

Absolute Moderate-to-severe angina (score of 3 or 4 on a 4-point scale). High risk of impending acute myocardial infarction.

Absolute Sustained ventricular tachycardia (VT) or other malignant arrhythmias. Immediate risk of hemodynamic collapse or sudden cardiac death.

Absolute ST elevation (>= 1.0 mm) in leads without diagnostic Q-waves (except V1/aVR). Suggests acute transmural myocardial injury / acute STEMI.

Absolute Signs of poor perfusion (cyanosis, pallor) or nervous system symptoms (dizziness, ataxia, syncope). Indicates critical compromise of cardiac output and cerebral perfusion.

Absolute Technical difficulties monitoring ECG or BP, or patient requests to stop. Inability to safely monitor the patient; overriding patient autonomy.

Relative Drop in systolic BP > 10 mmHg from baseline without other evidence of ischemia. May indicate latent LV dysfunction; warrants cautious clinical judgment.

Relative Significant ECG changes (> 2 mm horizontal or downsloping ST-segment depression). Strong indicator of ischemia, but can be managed if patient is asymptomatic and stable.

Relative Arrhythmias other than sustained VT (e.g., multifocal PVCs, SVT, heart block). May precede more malignant rhythms; evaluate patient tolerance.

Relative Exaggerated hypertensive response (SBP > 250 mmHg and/or DBP > 115 mmHg). Increased risk of stroke or acute decompensated heart failure.

Relative Fatigue, shortness of breath, wheezing, leg cramps, or claudication. Non-cardiac limiting factors; test may be nondiagnostic but safe to continue if mild.

Proper application of these criteria ensures patient safety while maximizing the diagnostic yield of the stress test. The supervising physician or qualified practitioner must remain intimately involved in the decision-making process throughout the procedure.

Target Heart Rate (85%) by Age